Encompass Health Corp (EHC) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US29261A1007
Encompass Health Corp financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 5.94 bn USD |
| EBIT | 1.08 bn USD |
| Net income | 566.20 m USD |
| Diluted EPS – continuing operations | 5.54 USD |
Full history since 1985, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Encompass Health Corp
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
More stocks
- Scentre Group (SCG.AX)
- Delivery Hero (DHER.DE)
- BrightSpring Health Services, Inc. (BTSG)
- Frontline Plc (FRO)
- Chubu Electric Power Co Inc (9502.T)
- RPM INTERNATIONAL INC/DE/ (RPM)
- Schroders PLC (SDR.L)
- Link Real Estate Investment Trust (823.HK)
- Pinnacle West Capital (PNW)
- Carrefour SA (CA.PA)
- Recordati Industria Chimica e Farmaceutica SpA (REC.MI)
- Prada SpA (1913.HK)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.